Department of Veterans Affairs

The $100 Million Texas Moonshot In a historic legislative shift, Texas has officially committed $100 million to fund the development of Ibogaine through the FDA drug approval process. This initiative represents the largest single investment in psychedelic research in history, aimed specifically at addressing the devastating impact of opioid addiction and traumatic brain injury (TBI) within the state and the broader United States. W. Bryan Hubbard, CEO of Americans for Ibogaine, confirmed that the funding was secured after a blistering five-and-a-half-month campaign to educate and persuade 188 Texas legislators. The bill received near-unanimous support, passing with 181 out of 188 votes across the Texas House of Representatives and the State Senate. The political maneuver required to unlock these funds involved high-stakes negotiations in the final hours of the budget cycle. Hubbard and former Texas Governor Rick Perry worked directly with Lieutenant Governor Dan Patrick and the House Speaker to ensure the project remained a priority. This move signals a departure from traditional Republican "tough on crime" drug policies, moving instead toward a model of medical intervention and healing. The Texas initiative is designed as a sovereign effort, meaning the state will lead the drug development independently, without relying on private pharmaceutical partners, to ensure the medicine remains accessible and focused on public health rather than profit margins. The Sophisticated Molecule from Gabon Ibogaine is a powerful alkaloid derived from the Ibogga shrub, which is native to the Congo basin, specifically Gabon. For centuries, the Bwiti spiritualists and indigenous tribes have used the plant in sacred rituals. Its modern medical utility was discovered in the 1960s when an individual addicted to heroin took the substance and experienced a complete interruption of withdrawal symptoms and cravings. This discovery touched off 60 years of field studies, though official U.S. research was stymied by the Nixon administration's War on Drugs, which placed the compound in Schedule I. The unique pharmacology of Ibogaine acts as a "reset button" for the brain's dopamine system. Unlike traditional addiction treatments that require months of abstinence or the use of maintenance drugs like methadone, Ibogaine appears to resolve physiological substance dependence in 48 to 72 hours. Hubbard explains that the molecule provides a profound interruption of compulsions, making it effective not just for opioids, but for alcohol, cocaine, methamphetamine, and even behavioral addictions like gambling. The treatment is intense, often described as a 12-to-16-hour state of semi-paralysis and physical purging, but it provides what Hubbard calls an "affirmation of individual human divinity." Healing the Wounds of War One of the most compelling arguments for the medicalization of Ibogaine comes from the U.S. Special Operations community. Since 2018, high-level veterans—including Navy SEALs like Marcus Latrell and Morgan Latrell—have been traveling to Mexico for treatment. These warfighters often return with symptoms of TBI, treatment-resistant depression, and suicidal ideation that the Veterans Affairs system has failed to cure with synthetic pharmacology. Governor Rick Perry witnessed this crisis firsthand when Marcus Latrell lived with him at the governor’s mansion for two years. Perry noted that while physical rehab helped manage symptoms, it was only Ibogaine that finally cleared the opioid addiction and neurological fog. New research from Stanford University, led by Dr. Nolan Williams, has utilized functional MRIs to show that Ibogaine has remarkable neuro-regenerative capacities. In study participants, brain scans that previously showed the "addicted look" of chronic opioid use returned to a normal, healthy state within 72 hours of a single dose. This rapid restoration of the prefrontal cortex—where focus, concentration, and emotional regulation reside—is unprecedented in Western medicine. A Multi-State Coalition Against Federal Bureaucracy The Texas victory has triggered a domino effect across the United States. Americans for Ibogaine is now coordinating with legislators in 22 states to form a unified front. Mississippi has already passed its own Ibogaine initiative, allocating $5 million from its opioid settlement funds to partner with Texas. Similar bills are advancing in Tennessee, Kentucky, Missouri, Oklahoma, and West Virginia. This "states-led" strategy is a deliberate attempt to bypass what Hubbard describes as a "corrupt and incompetent federal bureaucracy" that has favored pharmaceutical companies like Purdue Pharma over effective cures. Hubbard points to the DEA as a primary obstacle, specifically their refusal to honor the "Right to Try" law signed in 2018. While the law allows patients with life-threatening conditions to access medications that have cleared Phase I safety trials, the DEA has arbitrarily asserted that this does not apply to Schedule I substances. By forming a multi-state coalition, these leaders intend to use political and economic leverage to force a rescheduling of Ibogaine from Schedule I to Schedule II or III. They are also seeking sovereign partnerships with Native American tribes, such as the Choctaw Nation, to establish legal treatment centers on tribal land, potentially providing immediate access while the federal battle continues. Rick Perry’s Personal Transformation Former Governor Rick Perry has become the most unlikely advocate for psychedelic medicine. A self-described "hard no" on drugs for 40 years, Perry admits that his perspective was shaped by the Reagan era and the "Just Say No" campaign. However, his willingness to change his mind was sparked by his experience with criminal justice reform in the early 2000s, where he learned that rehabilitation was more effective than incarceration. He now refers to himself as the "Johnny Appleseed of Ibogaine." To ensure the legitimacy of his advocacy, Perry underwent the Ibogaine treatment himself in 2023. Although he did not have a substance abuse problem, he sought the treatment for the neuro-regenerative benefits to address three major concussions sustained in his youth. Perry shared that his post-treatment brain scans showed a 27% increase in activity in his prefrontal cortex. More strikingly, Dr. Charlie Gordon, a neurosurgeon and former skeptic, told Perry that six months after the treatment, the mild atrophy in his brain had completely disappeared, making his brain look like that of a 40-year-old. Perry emphasizes that he is willing to risk his lifelong political reputation because the lives of veterans and addicts are worth more than any individual’s status. The Spiritual Famine and the Future Beyond the clinical data and political maneuvering, Hubbard views the Ibogaine movement as an answer to a profound "spiritual famine" in America. He argues that modern power structures have monetized human misery, keeping people trapped in cycles of addiction and trauma. Ibogaine, according to Hubbard, acts as a "divine emancipator" that allows individuals to reclaim their autonomy and recognize their inherent value. This perspective is gaining traction even in conservative religious circles, with upcoming books like Wendy Reese’s *A Christian’s Guide to Psychedelics* providing a scriptural framework for the use of these plants. The long-term vision for Americans for Ibogaine is the full integration of the medicine into the U.S. healthcare system within three years. This "moonshot" aims to replace ineffective, opioid-based maintenance programs with a single, redemptive treatment. With Texas leading the charge and Gabon signing on as an official international partner, the momentum appears unstoppable. As Joe Rogan noted, the world is finally waking up to the idea that these maligned substances might hold the key to solving the most persistent crises of the modern age.